A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma
Clinical trial NCT05907122 · COMPLETED
Trial details
- NCT number
- NCT05907122
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-26
- Primary completion
- 2025-03-26
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.